Adlai Nortye (NASDAQ:ANL) Coverage Initiated at Leerink Partners

Equities research analysts at Leerink Partners assumed coverage on shares of Adlai Nortye (NASDAQ:ANL) in a report issued on Friday, Marketbeat Ratings reports. The brokerage set an “outperform” rating and a $23.00 price target on the stock. Leerink Partners’ price objective suggests a potential upside of 210.81% from the stock’s current price.

ANL has been the topic of several other research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a research report on Wednesday, January 21st. Wall Street Zen raised Adlai Nortye to a “hold” rating in a report on Saturday, March 7th. Finally, HC Wainwright upgraded shares of Adlai Nortye from a “neutral” rating to a “buy” rating and set a $16.00 price target on the stock in a research note on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $19.50.

Adlai Nortye Stock Up 0.5%

Shares of NASDAQ ANL opened at $7.40 on Friday. The business has a 50-day moving average of $7.25 and a two-hundred day moving average of $3.55. Adlai Nortye has a 1 year low of $0.88 and a 1 year high of $12.09.

Adlai Nortye Company Profile

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.